Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 25 EP applications Heather Woodcock-Bourne has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after July 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12719082

GLYCOSIDE DERIVATIVES AND USES THEREOF

IPC classification:
A61K 31/7034, C07H 19/24, C07H 19/044, C07H 15/203, C07H 15/14, C07H 15/12, C07H 15/04, C07H 13/04, C07D 417/10, C07D 413/10, C07D 407/10, A61P 3/00
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12719083

GLYCOSIDE DERIVATIVES AND THEIR USES FOR THE TREATMENT OF DIABETES

IPC classification:
A61K 31/70, C07D 405/10, A61P 3/10
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP12727947

3-SPIROCYCLIC PIPERIDINE DERIVATIVES AS GHRELIN RECEPTOR AGONISTS

IPC classification:
A61K 31/438, C07D 487/10, C07D 471/10, A61P 1/00
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12742994

NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/519, A61K 31/517, A61K 31/506, C07D 491/052, C07D 409/14, C07D 401/12, A61P 35/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742995

4-OXO-3,5,7,8-TETRAHYDRO-4H-PYRANO {4,3-D} PYRMINIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 31/519, C07D 491/052, A61P 35/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12742957

4 - PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS

IPC classification:
A61K 35/00, A61K 31/4523, C07D 513/04, C07D 498/04, C07D 495/04, C07D 491/04, C07D 487/04, C07D 471/04, C07D 401/14, C07D 401/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12758894

PYRAZOLINE DERIVATIVES AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS

IPC classification:
A61K 31/416, C07D 487/04, A61P 5/26
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12770249

BENZOTHIAZOLONE COMPOUND

IPC classification:
A61K 31/428, C07D 277/68, A61P 21/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP13197275

Pyrrolopyrimidine compounds and their uses

IPC classification:
A61K 31/519, C07D 487/04, A61P 35/00
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP13710040

5-MEMBERED HETEROARYLCARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

IPC classification:
C07D 403/14, C07D 403/12, C07D 403/10, C07D 401/14, C07D 401/06, C07D 231/14, A61P 27/00
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13709552

AMINOPYRIDINE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS

IPC classification:
A61K 31/444, A61K 31/4439, C07D 495/04, C07D 487/04, C07D 413/12, C07D 409/12, C07D 405/12, C07D 401/12, C07D 213/73, A61P 7/02
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13717320

SPIROHYDANTOIN COMPOUNDS AND THEIR USE AS SELECTIVE ANDROGEN RECEPTOR MODULATORS

IPC classification:
A61K 31/415, C07D 413/06, C07D 405/06, C07D 401/06, C07D 263/44, C07D 233/72
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13729090

L-MALATE SALT OF 2, 7 - DIAZA - SPIRO [4.5]DEC- 7 - YLE DERIVATIVES AND CRYSTALLINE FORMS THEREOF AS GHRELIN RECEPTOR AGONISTS

IPC classification:
A61K 31/438, C07D 487/10, C07D 471/10, A61P 1/00
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13192176

Salmonella conjugate vaccines

IPC classification:
A61K 47/48, A61P 31/04
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION REFUSED
EP13812075

SALTS OF BENZOTHIAZOLONE COMPOUND AS BETA-2-ADRENOCEPTOR AGONIST

IPC classification:
A61K 31/428, C07D 277/68, A61P 21/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
The patent has been granted
EP11779607

DIAZA-SPIRO[5.5]UNDECANES USEFUL AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61P 25/00, A61K 31/438, C07D 519/00, C07D 471/10
Applicant:
Novartis AG
Agent:
Heather Woodcock-Bourne, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13826612

PYRIMIDO [4,5-B]QUINOLINE-4,5 (3H,10H)-DIONES AS NONSENSE MUTATION SUPPRESSORS

IPC classification:
A61K 31/513, C07D 471/04, A61P 43/00, A61P 35/00, A61P 21/00, A61P 7/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14708700

FORMULATION COMPRISING BENZOTHIAZOLONE COMPOUND

IPC classification:
A61K 31/428, A61K 9/48, A61K 9/20
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED
EP14806081

RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS

IPC classification:
A61P 35/00, A61K 31/501, A61K 31/5377, A61K 31/5383, A61K 31/506, A61K 31/4353, A61K 31/437, A61K 31/4375, C07D 519/00, C07D 498/04, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15725195

CARBOXAMIDE DERIVATIVES

IPC classification:
A61P 19/08, A61P 19/02, A61P 9/12, A61P 11/00, C07D 413/12, A61K 31/422, A61K 31/4155, C07D 413/14
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15774680

CARBOXAMIDE DERIVATIVES

IPC classification:
C07D 487/04, A61P 19/08, A61P 19/04, A61P 19/02, A61P 9/12, A61K 31/4192, C07D 403/12
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15727117

COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS

IPC classification:
A61P 19/02, A61K 31/506, A61K 31/4245, A61K 31/415, A61K 31/44, A61K 31/352, C07D 493/08, C07D 491/18
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15731120

PYRIMIDO[4,5-b]QUINOLINE-4,5(3H,10H)-DIONE DERIVATIVES

IPC classification:
A61K 31/519, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15731121

NAPHTHYRIDINEDIONE DERIVATIVES

IPC classification:
C07D 495/14, C07D 471/14, A61K 31/44, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED
EP15731119

PYRIDOPYRIMIDINEDIONE DERIVATIVES

IPC classification:
C07D 495/14, A61K 31/505, A61K 31/38, C07D 471/04
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature